EP3046627
MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
15.9.2014EP published:
23.10.2019EP application number:
14845184.2
EPO information:
European Patent Register
Max expiry date:
14.9.2034
Title:
MODULATION OF EFFEROCYTOSIS PATHWAYS FOR TREATMENT OF ATHEROSCLEROTIC DISEASE
Timeline
Today
15.9.2014EP application
23.10.2019EP Publication
Owner
Name:
The Board of Trustees of the Leland Stanford Junior UniversityAddress:
Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, 94305-2038, Stanford, CA, US
Inventor
Name:
LEEPER, Nicholas J.Address:
Stanford, California, US
Name:
WEISSMAN, Irving L.Address:
Stanford, California, US
Priority
Number:
201361879562 PDate:
18.9.2013Country:
US
Classification
Categories:
A61K 31/519, A61K 31/7068, A61P 9/10